|
|
|
Volumn 47, Issue 3, 2017, Pages 69-76
|
|
Efficacy of valbenazine (NBI-98854) in treating subjects with tardive dyskinesia and schizophrenia or schizoaffective disorder
a a b b b |
|
Author keywords
Amines; Antipsychotic agents; Double blind method; Mood disorders; Psychopharmacology; Psychotic disorders; Schizophrenia; Tardive dyskinesia; Valbenazine
|
|
Indexed keywords
PLACEBO;
VALBENAZINE;
ADRENERGIC RECEPTOR AFFECTING AGENT;
NEUROLEPTIC AGENT;
SLC18A2 PROTEIN, HUMAN;
TETRABENAZINE;
VALINE;
VESICULAR MONOAMINE TRANSPORTER;
ABNORMAL INVOLUNTARY MOVEMENT SCALE;
ADULT;
ARTICLE;
BLACK PERSON;
BODY MASS;
CAUCASIAN;
CLINICAL GLOBAL IMPRESSION SCALE;
CLINICAL OUTCOME;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG DOSE COMPARISON;
DRUG EFFICACY;
FEMALE;
FOLLOW UP;
HUMAN;
INTENTION TO TREAT ANALYSIS;
MAJOR CLINICAL STUDY;
MALE;
MIDDLE AGED;
MOOD DISORDER;
NUMBERS NEEDED TO TREAT;
ONSET AGE;
OUTCOME ASSESSMENT;
POSITIVE AND NEGATIVE SYNDROME SCALE;
PRETEST POSTTEST DESIGN;
PSYCHOLOGICAL RATING SCALE;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOAFFECTIVE PSYCHOSIS;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
TREATMENT DURATION;
AGED;
ANALOGS AND DERIVATIVES;
ANTAGONISTS AND INHIBITORS;
CHEMICALLY INDUCED;
PSYCHOSIS;
ADRENERGIC UPTAKE INHIBITORS;
ADULT;
AGED;
ANTIPSYCHOTIC AGENTS;
DOUBLE-BLIND METHOD;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
PSYCHOTIC DISORDERS;
SCHIZOPHRENIA;
TARDIVE DYSKINESIA;
TETRABENAZINE;
VALINE;
VESICULAR MONOAMINE TRANSPORT PROTEINS;
|
|
EID: 85028358568
PISSN: 00485764
EISSN: 24722448
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (17)
|
|
References (2)
|
